Atlas Trials

Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer

Clinical trial NCT07115277 · RECRUITING

Trial details

NCT number
NCT07115277
Sponsor
Sinotau Pharmaceutical Group
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2025-03-14
Primary completion
2026-12-31
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.